Trial intelligence / Profile preview

Buspirone in the treatment of schizophrenia

IRCT138712051556N8Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of buspirone in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Apr 2006; status: completed.

02

Drugs

buspirone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT138712051556N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138712051556N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call